SCOPUS 정보 검색 플랫폼

Journal of the American Academy of Dermatology

Volumn 45, Issue 6, 2001, Pages 871-881

A multicenter dose-escalation trial with denileukin diftitox (ONTAK, DAB389IL-2) in patients with severe psoriasis

(10) Martin, Ann a Gutierrez, Elsa a Muglia, Jennie b McDonald, Charles J b Guzzo, Cynthia c Gottlieb, Alice d Pappert, Amy d Thomas Garland, W e Bagel, Jerry f Bacha, Patricia g

a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE (United States)

b BROWN UNIVERSITY (United States)

c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA (United States)

d ROBERT WOOD JOHNSON MEDICAL SCHOOL (United States)

e Lawrence Clinical Research (United States)

f Psoriasis Treatment Center of Central New Jersey (United States)

g Seragen Inc (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAB 389 IL 2; DENILEUKIN DIFTITOX;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PSORIASIS; SKIN ALLERGY;

EID: 17944381123 PISSN: 01909622 EISSN: None Source Type: Journal
DOI: 10.1067/mjd.2001.117852 Document Type: Article

Times cited : (77)

References (17)

1
- 0001880651
- An overview of psoriasis
- Weinstein GD, Gottlieb AB, editors. Portland (OR): National Psoriasis Foundation
- (1993) Therapy of Moderate-to-Severe Psoriasis , pp. 1-22
- Weinstein, G.D.¹ Krueger, J.G.²

2
- 0023109292
- The effects of cyclosporin A on T lymphocytes and dendritic cell sub-populations in psoriasis
- (1987) Br J Dermatol , vol.116 , pp. 503-510
- Baker, B.S.¹ Griffiths, C.E.M.² Lambert, S.³ Powles, A.V.⁴ Leonard, J.N.⁵ Valdimarsson, H.⁶

3
- 0024788033
- Use of cyclosporin in psoriasis
- (1989) Lancet , vol.2 , pp. 1500-1502
- Bos, J.D.¹ Meinardi, M.M.² VanJoost, T.³ Henle, F.⁴ Powles, A.V.⁵ Fry, L.⁶

4
- 0030002445
- Systemic tacrolimus (FK506) is effective for the treatment of psoriasis in a double-blind, placebo-controlled study
- (1996) Arch Dermatol , vol.132 , pp. 419-423

5
- 0029955912
- Cellular actions of etretinate in psoriasis: Enhanced epidermal differentiation and reduced cell-mediated inflammation are unexpected outcomes
- (1996) J Cutan Pathol , vol.23 , pp. 404-418
- Gottlieb, S.L.¹ Hayes, E.² Gilleaudeau, P.³ Cardinale, I.⁴ Gottlieb, A.B.⁵ Krueger, J.G.⁶

6
- 0025862110
- Chimaeric CD4 monoclonal antibody in treatment of generalized pustular psoriasis
- (1991) Lancet , vol.338 , pp. 320-321
- Prinz, J.¹ Braun-Falco, O.² Meurer, M.³ Daddona, P.⁴ Reiter, C.⁵ Reiber, P.⁶

7
- 0028223483
- PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: A possible cellular basis for remittive therapy
- (1994) J Exp Med , vol.180 , pp. 283-296
- Vallat, V.P.¹ Gilleaudeau, P.² Battat, L.³ Wolfe, J.⁴ Nabeya, R.⁵ Heftler, N.⁶

8
- 0028990380
- 389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis
- (1995) Nat Med , vol.1 , pp. 442-447
- Gottlieb, S.L.¹ Gilleaudeau, P.² Johnson, R.³ Estes, L.⁴ Woodworth, T.G.⁵ Gottlieb, A.B.⁶

9
- 0025336716
- 486IL-2): Fragment B sequences required for the delivery of fragment A to the cytosol of target cells
- (1990) J Biol Chem , vol.265 , pp. 11885-11889
- Williams, D.P.¹ Snider, C.E.² Strom, T.B.³ Murphy, J.R.⁴

10
- 0025287153
- Interleukin 2 receptor-targeted cytotoxicity. Receptor binding requirements for entry of a diphtheria toxin-related interleukin 2 fusion protein into cells
- (1990) Eur J Immunol , vol.20 , pp. 785-791
- Waters, C.A.¹ Schimke, P.A.² Snider, C.E.³ Itoh, K.⁴ Smith, K.A.⁵ Nichols, J.C.⁶

11
- 0035863468
- Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T cell lymphoma
- (2001) J Clin Oncol , vol.19 , pp. 376-388
- Olsen, E.¹ Duvic, M.² Frankel, A.³ Klm, Y.⁴ Martin, A.⁵ Vonderheid, E.⁶

12
- 0031594913
- 389IL-2 fusion toxin in mycosis fungoides
- (1998) J Am Acad Dermatol , vol.39 , pp. 63-73
- Saleh, M.N.¹ LeMaistre, C.F.² Kuzel, T.M.³ Foss, F.⁴ Platanias, L.C.⁵ Schwartz, G.⁶

13
- 17744401939
- 389IL-2) in lymphomas expressing the receptor for interleukin-2
- (1998) Blood , vol.91 , pp. 399-405
- LeMaistre, C.F.¹ Saleh, M.N.² Kuzel, T.M.³ Foss, F.⁴ Platanias, L.C.⁵ Schwartz, G.⁶

14
- 0031596951
- 389IL2 diphtheria fusion toxin produces clinical responses in tumor stage cutaneous T cell lymphoma
- (1998) Am J Hematol , vol.58 , pp. 87-90
- Duvic, M.¹ Cather, J.² Maize, J.³ Frankel, A.E.⁴

15
- 0031954067
- 389IL-2, for the treatment of psoriasis
- (1998) Dermatol Ther , vol.5 , pp. 48-63
- Gottlieb, A.B.¹ Bacha, P.² Parker, K.³ Strand, V.⁴

16
- 0032085463
- 389IL-2 to patients with recalcitrant psoriasis: A double-blind, phase II multicenter trial
- (1998) J Am Acad Dermatol , vol.38 , pp. 938-944
- Bagel, J.¹ Garland, W.T.² Breneman, D.³ Holick, M.⁴ Littlejohn, T.W.⁵ Crosby, D.⁶

17
- 0018099294
- Severe psoriasis: Oral therapy with a new retinoid
- (1978) Dermatologica , vol.157 , pp. 238-244
- Fredriksson, T.¹ Pettersson, U.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.